Children's, infants' Tylenol, Motrin, Zyrtec, Benadryl recalled

FORT WASHINGTON, Pa.

McNeil Consumer Healthcare, in consultation with the U.S. Food and Drug Administration, is voluntarily recalling certain over-the-counter children's and infants' Tylenol, Motrin, Zyrtec and Benadryl products manufactured in the United States and distributed in the United States, Canada and 11 other countries.

McNeil said no adverse medical events have occurred, but some of the products may contain a higher concentration of an active ingredient than specified; others may contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles.

The company said the potential for serious medical events is remote, but consumers should discontinue use of the products.

The company is conducting a comprehensive quality assessment and has identified corrective actions that will be implemented before new manufacturing is initiated at the plant where the products were made.

Consumers can contact the company at 1-888-222-6036 or www.mcneilproductrecall.com. Parents and caregivers who are not sure about alternative pediatric health treatment options should talk to their doctor or pharmacist.

Additional information is available on the company's Web site or by phone from 8 a.m. to 10 p.m. Monday through Friday, and 9 a.m. to 5 p.m. weekends. Any adverse reactions may be reported to the FDA’s MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, Md. 20852-9787, or on www.fda.gov/medwatch.